Lisa Khorey - 05 Aug 2021 Form 4 Insider Report for ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (MDRX)

Reporting relationship: Chief Client Delivery Officer
Issuer ticker: MDRX
Reported as of: 05 Aug 2021
Net transaction value: -$857,022
SEC form: 4
Accepted by SEC: 06 Aug 2021, 17:02:23 UTC
Prior SEC filing: 15 Jun 2021
Source filing: View source filing
Reporting owner signature: Holly O'Berry by power of attorney for Lisa Khorey

Key filing fact

Lisa Khorey filed Form 4 for ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (MDRX) on 06 Aug 2021.

Key facts

This page summarizes Lisa Khorey's Form 4 filing for ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (MDRX).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 06 Aug 2021, 17:02.

Change

Previous filing in this sequence was filed on 15 Jun 2021.
Current net transaction value: -$857,022.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDRX transaction

Common Stock

Sale

Transaction value: $805,599
Shares: -47,000
Change %: -22%
Price: $17.14
Shares after: 169,308
Date: 05 Aug 2021
Ownership: Direct
Footnotes: F1, F2

MDRX transaction

Common Stock

Sale

Transaction value: $51,424
Shares: -3,000
Change %: -1.8%
Price: $17.14
Shares after: 166,308
Date: 05 Aug 2021
Ownership: Direct
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Lisa Khorey is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 3 footnotes

Footnote F1

The sale of shares reported in the Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2021.

Footnote F2

These transactions were executed in multiple trades at prices ranging from $17.04 to $17.24. The prices reported reflect the weighted average sale price on the transaction date. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Footnote F3

These transactions were executed in multiple trades at prices ranging from $17.06 to $14.23. The prices reported reflect the weighted average sale price on the transaction date. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.